CD70 and renal cell carcinoma: ,3 Furthermore, the protocol details procedures for evaluating antitumor efficacy using in vitro tumor cell killing assays with RCC cell lines that exhibit varying levels of CD70 expression, thereby modeling different antigen-density scenarios.